| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |